🎁 Black Friday: up to 50% off of annual plans
Cowealth Medical China Co.,Ltd. (SHA:603122)
China flag China · Delayed Price · Currency is CNY
8.57
-0.63 (-6.85%)
At close: Nov 20, 2026

Cowealth Medical China Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
639.72677.51938.791,0921,2791,191
Other Revenue
0.280.280.350.330.330.32
640677.79939.141,0931,2801,191
Revenue Growth
-17.64%-27.83%-14.05%-14.62%7.44%9.37%
Cost of Revenue
536.98583.02763.98870.461,024943.35
Gross Profit
103.0294.77175.16222.14255.43247.71
Selling, General & Admin
116.59120.73147.76158.86147.54139.23
Research & Development
3.663.813.753.182.8-
Other Operating Expenses
0.31-1.17-1.18-1.493.753.45
Operating Expenses
135.56136.07140.09157.67156.56145.67
Operating Income
-32.55-41.335.0764.4898.87102.03
Interest Expense
-1.73-2.32-3.32-5.88-4.24-4.55
Interest & Investment Income
2.965.664.159.349.774.67
Currency Exchange Gain (Loss)
-0.91-0.910.92-0.030.78-0.22
Other Non Operating Income (Expenses)
0.78-0.770.21-3.88-0.270.76
EBT Excluding Unusual Items
-31.45-39.6437.0364.04104.91102.69
Gain (Loss) on Sale of Investments
-0.51-0.21-1.15-1.38--
Gain (Loss) on Sale of Assets
-0.050.040.440.08-0.16-0
Asset Writedown
0.51-----
Other Unusual Items
-0.41-0.313.152.969.16.83
Pretax Income
-31.9-40.1239.4765.7113.84109.52
Income Tax Expense
-5.17-6.431118.5431.1329.35
Earnings From Continuing Operations
-26.73-33.6928.4747.1682.7280.16
Minority Interest in Earnings
-0.160.04-0.90.0300.07
Net Income
-26.9-33.6427.5747.1982.7280.23
Net Income to Common
-26.9-33.6427.5747.1982.7280.23
Net Income Growth
---41.58%-42.96%3.10%10.58%
Shares Outstanding (Basic)
420421394393376297
Shares Outstanding (Diluted)
420421394393376297
Shares Change
2.87%6.79%0.15%4.58%26.53%-1.71%
EPS (Basic)
-0.06-0.080.070.120.220.27
EPS (Diluted)
-0.06-0.080.070.120.220.27
EPS Growth
---41.67%-45.45%-18.52%12.50%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-79.63.47100.93-56.68-56.31-15.11
Free Cash Flow Per Share
-0.190.010.26-0.14-0.15-0.05
Dividend Per Share
--0.1300.0600.1500.180
Dividend Growth
--116.67%-60.00%-16.67%-
Gross Margin
16.10%13.98%18.65%20.33%19.96%20.80%
Operating Margin
-5.08%-6.09%3.73%5.90%7.73%8.57%
Profit Margin
-4.20%-4.96%2.94%4.32%6.46%6.74%
Free Cash Flow Margin
-12.44%0.51%10.75%-5.19%-4.40%-1.27%
EBITDA
-24.76-33.8142.1771.65106.92112.66
EBITDA Margin
-3.87%-4.99%4.49%6.56%8.36%9.46%
D&A For EBITDA
7.787.497.17.178.0510.63
EBIT
-32.55-41.335.0764.4898.87102.03
EBIT Margin
-5.08%-6.09%3.73%5.90%7.73%8.57%
Effective Tax Rate
--27.87%28.21%27.34%26.80%
Revenue as Reported
640677.79939.141,0931,2801,191
Advertising Expenses
-2.374.063.614.652.32